ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

BACKGROUND: Polymorphisms in the excision repair cross-complimentary group 1 (ERCC1) gene have been involved in the prognosis of various cancers. In the present study, we evaluated the prognostic role of the two most common ERCC1 polymorphisms in patients with T4 breast cancer receiving platinum-bas...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Palomba, Grazia, Atzori, Francesco, Budroni, Mario, Ombra, MariaNeve, Cossu, Antonio, Sini, MariaCristina, Pusceddu, Valeria, Massidda, Bruno, Frau, Barbara, Notari, Francesca, Ionta, MariaTeresa, Palmieri, Giuseppe
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4177579/
https://ncbi.nlm.nih.gov/pubmed/25253066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0272-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires